BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18331475)

  • 1. Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.
    Sanz E; Quintana A; Battaglia V; Toninello A; Hidalgo J; Ambrosio S; Valoti M; Marco JL; Tipton KF; Unzeta M
    J Neurochem; 2008 Jun; 105(6):2404-17. PubMed ID: 18331475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel MAO-B inhibitors: potential therapeutic use of the selective MAO-B inhibitor PF9601N in Parkinson's disease.
    Unzeta M; Sanz E
    Int Rev Neurobiol; 2011; 100():217-36. PubMed ID: 21971010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] confers MAO-B independent neuroprotection in ER stress-induced cell death.
    Sanz E; Quintana A; Hidalgo J; Marco JL; Unzeta M
    Mol Cell Neurosci; 2009 May; 41(1):19-31. PubMed ID: 19386233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cells.
    Mathiasen JR; McKenna BA; Saporito MS; Ghadge GD; Roos RP; Holskin BP; Wu ZL; Trusko SP; Connors TC; Maroney AC; Thomas BA; Thomas JC; Bozyczko-Coyne D
    Brain Res; 2004 Apr; 1003(1-2):86-97. PubMed ID: 15019567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bee venom protects SH-SY5Y human neuroblastoma cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death.
    Doo AR; Kim SN; Kim ST; Park JY; Chung SH; Choe BY; Chae Y; Lee H; Yin CS; Park HJ
    Brain Res; 2012 Jan; 1429():106-15. PubMed ID: 22078207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.
    Wang XJ; Xu JX
    Neurosci Res; 2005 Feb; 51(2):129-38. PubMed ID: 15681030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
    Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
    Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
    Le W; Jankovic J; Xie W; Kong R; Appel SH
    Neurosci Lett; 1997 Mar; 224(3):197-200. PubMed ID: 9131670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death.
    Zhu G; Wang X; Wu S; Li Q
    Neurochem Int; 2012 Mar; 60(4):400-8. PubMed ID: 22265823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis.
    Cheng YF; Zhu GQ; Wang M; Cheng H; Zhou A; Wang N; Fang N; Wang XC; Xiao XQ; Chen ZW; Li QL
    Neurosci Res; 2009 Jan; 63(1):52-8. PubMed ID: 19022306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
    Pérez V; Morón J; Pastó M; Unzeta M
    Neurobiology (Bp); 2000; 8(3-4):231-6. PubMed ID: 11225513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1.
    Yang HJ; Wang L; Xia YY; Chang PN; Feng ZW
    Neurochem Int; 2010 Jan; 56(1):128-34. PubMed ID: 19778565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells.
    An H; Kim IS; Koppula S; Kim BW; Park PJ; Lim BO; Choi WS; Lee KH; Choi DK
    J Ethnopharmacol; 2010 Jul; 130(2):290-8. PubMed ID: 20470875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.
    Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST
    Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.
    Fitzgerald JC; Ufer C; De Girolamo LA; Kuhn H; Billett EE
    J Neurochem; 2007 Dec; 103(6):2189-99. PubMed ID: 17883400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
    Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG
    Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.
    Alvira D; Tajes M; Verdaguer E; de Arriba SG; Allgaier C; Matute C; Trullas R; Jiménez A; Pallàs M; Camins A
    Neuroscience; 2007 Apr; 146(1):350-65. PubMed ID: 17343987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Okadaic acid protects human neuroblastoma SH-SY5Y cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis.
    Ahn KH; Kim YS; Kim SY; Huh Y; Park C; Jeong JW
    Neurosci Lett; 2009 Jan; 449(2):93-7. PubMed ID: 19000740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of MPP(+)-induced cell death in a dopaminergic neuronal cell line: role of macromolecule synthesis, cytosolic calcium, caspase, and Bcl-2-related proteins.
    Choi WS; Canzoniero LM; Sensi SL; O'Malley KL; Gwag BJ; Sohn S; Kim JE; Oh TH; Lee EB; Oh YJ
    Exp Neurol; 1999 Sep; 159(1):274-82. PubMed ID: 10486196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.